Advanced in Bladder Outlet Obstruction

Camille Chesnel

GREEN Group Of Clinical REsEarch In Neurourology, GRC 01, 
Paris, FR 
Advanced in Bladder Outlet Obstruction
GREEN Group Of Clinical REsEarch In Neurourology, GRC 01, 
Paris, FR 
OverviewLocationsClinical Research

Overview

Camille Chesnel practices in Paris, France. Ms. Chesnel is rated as an Advanced expert by MediFind in the treatment of Bladder Outlet Obstruction. Her top areas of expertise are Neurogenic Bladder, Bowel Incontinence, Urinary Incontinence, and Stress Urinary Incontinence.

Her clinical research consists of co-authoring 89 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Bladder Outlet Obstruction.

Gender
Female

Locations

GREEN Group Of Clinical REsEarch In Neurourology, GRC 01, Paris, 75013, France
Other Locations
Thenon, France
Garches, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Filling and Emptying Cystometries: a Feasibility and Validation Study in Order to Simplify the Manometric Follow-up of Overactive Detrusor in Neurological Patients Under Anticholinergic or Botulinum Toxin Injections.
Filling and Emptying Cystometries: a Feasibility and Validation Study in Order to Simplify the Manometric Follow-up of Overactive Detrusor in Neurological Patients Under Anticholinergic or Botulinum Toxin Injections.
Enrollment Status: Completed
Publish Date: September 25, 2019
Intervention Type: Other

89 Total Publications

Correction: Clinical and urodynamic benefit of adding antimuscarinics after a loss of efficacy of intradetrusor botulinum toxin in patients with multiple sclerosis.
Correction: Clinical and urodynamic benefit of adding antimuscarinics after a loss of efficacy of intradetrusor botulinum toxin in patients with multiple sclerosis.
Journal: World journal of urology
Published: September 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Chesnel's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile